Post by
woundedknee on Oct 15, 2021 2:49pm
The share price
The share price was staying in the 1.20 range on the hope of a positive revision of the otenaproxesul situation. This drug ,as of yesterday, is now dead in the water. Even the spin putting it to be a pain reliever for post op is miles away from acceptance. Nasdag listing is dead. Dan has been on the edge of betraying his shareholders from the phase two trials and the low dose exclusion, plus the questionable sale (twice) of thousands of shares, quite conveniently I might add. He must go, regardless of what Mugsy says. His credibility is shot imo. This from a past shareholder who lost 120 grand based on his glowing update just a mere 7 days before the crash. There has to be new blood to head up this company if only to rebuild credibility. Too many questions remained unanswered. Of course this is only my opinion.
Comment by
Nick80 on Oct 15, 2021 3:15pm
I feel your comment - Dan should step up and share openly what is going in the company and provide concrete information or step down and retire. Its about that time and than let someone younger take over who is able to convey information fluently and more important accurately and precise. So disappointed !